Antibody–Drug Conjugates for Cancer Therapy

Antibody–drug conjugates (ADCs) take advantage of the specificity of a monoclonal antibody to deliver a linked cytotoxic agent directly into a tumour cell. The development of these compounds provides exciting opportunities for improvements in patient care. Here, we review the key issues impacting on...

Full description

Saved in:
Bibliographic Details
Published in:Biomedicines
Main Authors: Parslow, Adam C., Parakh, Sagun, Lee, Fook-Thean, Gan, Hui K., Scott, Andrew M.
Format: Artigo
Language:Inglês
Published: MDPI 2016
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5344263/
https://ncbi.nlm.nih.gov/pubmed/28536381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines4030014
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items